FDA Clearance Tracker · P830055-S351
Attune Revision Knee System
Last checked: Nov 20, 2026Latest source record: Sep 21, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Sep 21, 2026
Approved
Time to decision
360 days
Received Sep 26, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P830055-S351
- Device name
- Attune Revision Knee System
- Applicant
- Depuy, Inc.
- Applicant location
- Warsaw, IN
- Received
- Sep 26, 2025
- Decided
- Sep 21, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P830055
Device type
- Device type
- Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing (NJL)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for the following two changes for the Attune Revision CRS Rotating Platform (CRS RP) tibial insert components of the Attune Revision Knee System:i. change in the manufacturing consolidation process to add ram extrusion as an alternative to compression molding for bar stock material antioxidant (Pentaerythritol tetrakis [3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate]) (AOX), Ultra-High Molecular Weight Polyethylene (UHMWPE) material of the aforementioned components.ii. change in sterilization dose from a single, high dose sterilization to a split-dose sterilization method through a combination of crosslinking AOX UHMWPE raw material and final terminal sterilization of the aforementioned components.
Source documents
Other decisions for Depuy, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.